Article Text

A2.14 Human mast cells engulf and store exogenous IL-17A
  1. T Noordenbos1,2,
  2. J Paramarta1,
  3. I Blijdorp1,2,
  4. L van Mens1,
  5. J Stap3,
  6. R Hoebe3,
  7. E Mul4,
  8. E Lubberts5,
  9. N Yeremenko1,2,
  10. DL Baeten1,2
  1. 1Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center, University of Amsterdam, Amsterdam, The Netherlands
  2. 2Laboratory of Experimental Immunology, Academic Medical Center/University of Amsterdam, The Netherlands
  3. 3Department of Cell Biology and Histology, Academic Medical Centre, University of Amsterdam, The Netherlands
  4. 4Sanquin Research, Landsteiner Laboratory and Academic Medical Center/University of Amsterdam, The Netherlands
  5. 5Department of Rheumatology, University of Rotterdam, Erasmus Medical Center, Rotterdam, The Netherlands


Background The emerging role of IL-17A in immune-mediated inflammatory diseases urges characterisation of the cellular source. Numerous recent studies have described the presence of IL-17A-positive mast cells in inflamed target tissues. Since mouse studies have not indicated mast cells as IL-17A producers, we investigated the mechanism of IL-17A expression by human mast cells.

Methods Quantitative PCR and Western blot analysis was performed on mast cells and CD4+ T-cells FACS-purified from human tonsils, ex vivoand after stimulation with PMA/ionomycin. Uptake of exogenous protein was analysed by microscopy, imaging-flowcytometry, live imaging and Western blot. DynaminII-inhibitor was used to block endocytosis.

Results Strikingly, gene expression analysis of highly purified primary mast cells failed to detect both IL-17A, IL-17F and their transcription factor RAR-related orphan receptor C (RORC), even after stimulation. Although RORC was also absent on the protein level, IL-17A was abundantly detected, conflicting with the mRNA data. Subsequent analysis of subcellular location showed the presence of IL-17A in lysosomal storage granules and in early endosomes, suggesting a role for endocytosis. We investigated whether mast cells are capable of internalising exogenous IL-17A in vitro. Microscopy, imaging-flowcytometry and Western blot analysis indicated that LAD2 mast cell line as well as primary mast cells are able to engulf exogenous IL-17A, but not TNFa. Live imaging revealed further that internalisation of IL-17A is specific and can be halted by blocking clathrin-mediated endocytosis.

Conclusion This data strongly suggest that human mast cells do not produce IL-17A, but rather engulf exogenous IL-17A from the inflamed milieu and store it in granules. Molecular mechanisms of IL-17A uptake and the contribution of this process to disease are currently under investigation.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.